1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer

1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer

Bibliographic Details
Main Authors: María Hernández, Simon Dohrmann, James Levin, Nicholas Dedeic, Amanda Almaguer, Doug Zuill, Elizabeth Abelovski, Rajvir Grewal, Joanne Fortier, Qiping Zhao, Karin Amundson, Madison Moniz, Hongyuan Chen, Dhanya Panicker, Thanh Lam, Thomas P Brady, Allen Borchardt, Jason N Cole, Leslie W Tari
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items